Biogaia

Biogaia EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Biogaia (BIOG B.ST) as of Nov 16, 2026 is 25.81 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 20.81 % — a change of 24.02% (higher).

EBIT/Assets

25.81 %

YoY

24.02%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Biogaia is 2025 25.81 % . Operating Income to Assets Ratio (EBIT/Assets) of Biogaia was 2024 20.81 % . It decreases by 24.02% higher compared to the previous year.

The Biogaia EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2018
42.03 SEK
Jan 1, 2019
36.42 SEK
Jan 1, 2020
11.92 SEK
Jan 1, 2021
11.92 SEK
Jan 1, 2022
16.33 SEK
Jan 1, 2023
18.98 SEK
Jan 1, 2024
20.81 SEK
Jan 1, 2025
25.81 SEK
The Biogaia EBIT/Assets history
YEAREBIT/AssetsYoY
25.81 %+24.02%
20.81 %+9.68%
18.98 %+16.24%
16.33 %+36.93%
11.92 %-0.01%
11.92 %-67.26%
36.42 %-13.34%
42.03 %+3.54%
40.59 %-0.49%
40.79 %+26.82%
32.16 %-32.11%
47.37 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biogaia Stock analysis

What does Biogaia do? BioGaia AB generates revenue through its probiotic product segments, primarily featuring Limosilactobacillus reuteri strains. The Paediatrics segment sells drops, gut health tablets, oral rehydration solutions, and cultures for licensee products. The Adult Health segment offers gut health tablets, oral health lozenges, and cultures integrated into dairy products by licensees. The Other segment includes royalties from development projects and revenue from CapAble's packaging solutions. Products are marketed globally to consumers seeking health benefits from probiotics, with licensees distributing branded items under agreements. The company targets health-conscious consumers through direct sales and licensed partnerships. Paediatrics products focus on infant and child health, while Adult Health products address digestive and oral wellness. CapAble, a subsidiary, contributes through packaging solutions, and royalties from development projects provide additional income streams. All segments operate under BioGaia's brand, leveraging documented health benefits of their probiotic strains. Biogaia is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biogaia stock

Operating Income to Assets Ratio (EBIT/Assets) of Biogaia is 25.81 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of Biogaia changed from 20.81 % to 25.81 %, representing a 24.02% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Biogaia since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Biogaia with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Biogaia

All Key Metrics — Biogaia